A Phase IB Trial of Autologous Cytokine-Induced Killer Cells in Combination with Sintilimab, Monoclonal Antibody Against Programmed Cell Death-1, plus Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer

Li Zhou,Yanjuan Xiong, Yang Wang,Yuan Meng,Weihong Zhang,Meng Shen,Xinwei Zhang,Shuzhan Li,Baozhu Ren,Runmei Li,Ying Han,Jiali Zhang,Shui Cao,Weijiao Du,Qian Sun,Feng Wei,Xiumei An,Lili Yang,Yuwei Zhang,Wenchao Ma,Wengui Xu,Yi Zhang,Jingting Jiang,Xiang Xu,Jianchuan Xia, Liang Liu,Xiubao Ren

Clinical lung cancer（2022）

引用 7|浏览37
暂无评分
关键词
NSCLC,CIK,PD-1 Inhibitor,Safety,Efficacy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要